Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | Group President | November 11, 2022 | November 15, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date November 11, 2022 · Filed November 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 202,443 |
Ending reported balance
After 2022-11-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-11-11 · Exercise / conversion · Acquired 12,000 · Balance 211,883 Row 2 · 2022-11-11 · Tax withholding · Disposed 9,440 · Balance 202,443 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $145.24 · Expires 2030-01-29 | Direct | 23,880 |
Reported balance
After 2022-11-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-11-11 · Exercise / conversion · Disposed 12,000 · Balance 23,880 F1: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Family GRAT | 4,525 |
Reported balance
Holding disclosure · report date 2022-11-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,525 |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2019 Filed Jan 31, 2020 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005881 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,974 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 14,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,875 Underlying: Common Stock · 14,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 52,250 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,250 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 55,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 68,184 | $138.05 | $9,412,801.20 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,879 Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 14,000 | $47.97 | $671,580.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 107,250 | $37.18 | $3,987,555.00 |
DisclosureSEC source: 0001209191-19-057346 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2019 Filed Jan 31, 2020 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005881 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,174 Read SEC document |
| November 06, 2019 Filed Jan 31, 2020 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005881 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,546 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014282 · doc4.xml · derivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,941 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 3,881 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 719 | $143.26 | $103,003.94 |
DisclosureSEC source: 0001209191-19-014282 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,941 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-014282 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,219 | $142.01 | $457,130.19 |
DisclosureSEC source: 0001209191-19-013232 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,719 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 10,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013232 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,938 F1 · kind: On January 29, 2016, the reporting person was granted 8,850 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 29,330 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-19-006552 · doc4.xml · derivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,330 Underlying: Common Stock · 29,330 shares Expires 2029-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| November 15, 2018 Filed Feb 1, 2019 17:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006552 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,119 Read SEC document |
| November 14, 2018 Filed Feb 1, 2019 17:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006552 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,397 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 75,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 75,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 34,125 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,125 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 75,068 | $130.16 | $9,770,850.88 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · nonDerivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,931 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 150,000 | $22.95 | $3,442,500.00 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 34,125 | $129.93 | $4,433,861.25 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,999 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 34,125 | $17.33 | $591,386.25 |
DisclosureSEC source: 0001209191-18-045765 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941 Underlying: Common Stock · 1,940 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 3,881 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,661 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 3,321 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,333 | $100.84 | $134,419.72 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,999 Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 3,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 5,625 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 5,625 shares Expires 2024-02-05 F3 · balance_after: On February 5, 2014, the reporting person was granted 37,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,625 stock appreciation rights. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 7,556 | $100.54 | $759,680.24 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,731 Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 19,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013636 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,287 F1 · kind: On February 4, 2015, the reporting person was granted 9,600 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 13 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 12 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 16,996 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 11 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,996 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,375 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 10 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,125 Underlying: Common Stock · 3,375 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 8 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,087 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 15,757 | $101.07 | $1,592,500.11 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,037 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.03 to $101.161, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 13,621 | $101.40 | $1,381,169.40 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,794 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 10,000 | $22.10 | $221,000.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 12,500 | $21.35 | $266,875.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 20,371 | $17.33 | $353,029.43 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,504 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · derivative · entry 9 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,996 Underlying: Common Stock · 20,504 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 20,504 | $101.40 | $2,079,105.60 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,544 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 19:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 20,504 | $17.33 | $355,334.32 |
DisclosureSEC source: 0001209191-18-012729 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 119,637 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-011084 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 119,637 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 95,293 | $100.19 | $9,547,567.67 |
DisclosureSEC source: 0001209191-18-011084 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,544 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.97, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 24,344 | $99.96 | $2,433,445.72 |
DisclosureSEC source: 0001209191-18-011084 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,837 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.94 to $99.9901, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 119,637 | $22.64 | $2,708,761.14 |
DisclosureSEC source: 0001209191-18-011084 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 102,629 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,637 Underlying: Common Stock · 102,629 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 35,949 | $103.09 | $3,706,154.97 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,544 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.33, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.